The purpose of this study is to: Compare the effect of paracetamol alone against NSAIDs alone against the association of paracetamol + NSAIDs in the treatment of traumatic pain.
Paracetamol, NSAIDs, or a combination of the two molecules are usually prescribed. Patients even use these medications without a prescription. It is not known, however, whether or not NSAIDs have an additional value relative to paracetamol for the treatment of pain. All patients were assigned in a 1:1:1 ratio. Randomization of subjects was performed centrally according to a computer-generated random code provided by one of investigators who was not involved in any other part of the trial. The patients included were divided into 3 groups: Paracetamol group who received paracetamol 1000 mg orally every 8th hour for 7 days; NSAID group who received piroxicam 20 mg orally twice a day for 7 days, and Paracetamol-NSAID combination who received both treatments at the same doses for 7 days. All protocol treatments were administered in opaque packets with code number according to the randomization list by an independent nurse who was not involved in monitoring or follow-up of the individuals. Data were collected for each patient, including demographics, medical history, and findings of the clinical examination. Injury Severity Score (ISS) whose values range from 0 to 75 was also assessed. Each patient was re-evaluated on the 3rd and 7th day post-trauma (D7) using a telephone contact by a clinical research associates who was blinded to the details of the study to note the following clinical data: pain VNS, ED readmissions for residual pain, need for other analgesics other than those of the protocol, other treatment modalities the patient might have used (adherence to the treatment prescribed), and side effects. In addition patients were asked about their satisfaction with pain control following ED using five point Likert scale: very dissatisfied, not satisfied, neutral, satisfied and very satisfied and about the degree to which they adhered to medication schedule. The principal investigator who was aware of the allocation was not involved in monitoring or recording of the outcomes until the data collection was completed.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
1,500
21 pills of Paracetamol 1000mg are provided with a preconised dose of 1 pill 3 times per day over 7 days period
14 pills of piroxicam 20 mg are provided with a preconised dose of 1 pill 2times per day over 7 days period
21 identical pills of paracetamol ith a preconised dose of 1 pill 3 times per day over 7 days period+14 pills of piroxicam 20 mg are provided with a preconised dose of 1 pill 2times per day over 7 days period
Monastir University Hospital
Monastir, Tunisia
new oral analgesic medications needed rate
oral analgesic medications other than those of the protocol prescribed by the treating physicians or taken by patients' own volition
Time frame: 3 days and 7 days
the between-group difference in mean change in VNS score measured from ED discharge (VNS D0) to 7 days later
\[delta VNS= (VNS D0 - VNS D7 / VNS D0) x 100\]
Time frame: 3 and 7 days
The appearance of side effects
The appearance of side effects: such as Drowsiness ,Decreased respiratory rate (\<14 c / min), Cutaneous rash, Vomiting,Nausea,pruritus, Dizziness. • Digestive hemorrhage.
Time frame: 7 days
the rate of ED readmissions for residual pain
ED readmissions for residual pain
Time frame: 3 and 7 days
patient satisfaction assessed by Likert's verbal scale.
patient satisfaction assessed by Likert's verbal scale.
Time frame: 3 and 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.